Table 5 Stratified analysis of the relationship between changes in EBSMRs and PHNs (n = 1601)
Variables of change (2015–2010) | Stratified analysis by baseline population | Stratified analysis by baseline EBSMRs | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Population < 10,000 | Population ≥ 10,000 | EBSMR < 100 | EBSMR ≥ 100 | |||||||
(n = 470) | (n = 1131) | |||||||||
Coefb | P-value | Coefb | P-value | (n) | Coefb | P-value | (n) | Coefb | P-value | |
EBSMRs in malesa | ||||||||||
All causes of death | -1.81 | 0.009 | -1.00 | 0.026 | (780) | 0.20 | 0.638 | (821) | -1.90 | 0.001 |
Malignant neoplasms | -2.41 | 0.005 | 0.02 | 0.966 | (960) | -0.23 | 0.668 | (641) | -1.59 | 0.015 |
Heart disease in males | 1.61 | 0.371 | -0.38 | 0.676 | (745) | 1.16 | 0.188 | (856) | -0.88 | 0.541 |
Cerebrovascular disease | -2.18 | 0.321 | -2.21 | 0.065 | (755) | 1.09 | 0.335 | (846) | -2.43 | 0.128 |
EBSMRs in femalesa | ||||||||||
All causes of death | -0.96 | 0.309 | -0.31 | 0.536 | (844) | -0.95 | 0.084 | (757) | -0.36 | 0.624 |
Malignant neoplasms | -0.13 | 0.906 | 0.88 | 0.126 | (1120) | 0.47 | 0.442 | (481) | -0.30 | 0.715 |
Heart disease | -1.83 | 0.341 | -0.91 | 0.352 | (800) | -2.09 | 0.040 | (801) | -0.18 | 0.909 |
Cerebrovascular disease | -2.57 | 0.283 | -1.53 | 0.203 | (808) | -0.86 | 0.443 | (793) | -0.52 | 0.780 |